Vir Biotechnology, Inc.

NASDAQ:VIR

Biotechnology

Healthcare
$8.87 -2.63%

-$0.25 today

Market cap
$1.52B
Beta
1.64
P/E (TTM)
-3.0
EPS (TTM)
-$3.00
52W Low $4.16High $11.66

Volume 1.89M

Average 1.76M

Returns on capital

Vir Biotechnology, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-57.2%

avg 0.4%

ROIC

-50.9%

avg -29.7%

ROA

-43.7%

avg -24.7%

Analysis

ROA is currently the strongest return metric at -43.7% versus its period average of -24.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Marianne De Backer

President, CEO & DirectorUSD 2.03M57286.65K0.17%

Jeff Calcagno

Executive Vice President & Chief Business OfficerUSD 860.49K65——

Vanina De Verneuil

Executive Vice President, General Counsel & Corporate SecretaryUSD 844.34K47110.19K0.07%

Lawrence Corey

Co-Founder & Scientific AdvisorUSD 177.66K79——

Louis J. Picker

Co-Founder & Scientific AdvisorUSD 177.66K———

Jennifer Eileen Towne

Executive Vice President & Chief Scientific Officer————

Kiki Patel

Head of Investor Relations————

Maninder Hora

Executive Vice President & Chief Technical Operations Officer—72——

Aziz Sawaf

Executive VP, CFO & Principal Financial Officer—440<0.01%

Brent Sabatini

Senior Vice President, Principal Accounting Officer & Chief Accounting Officer—5261.90K0.04%

Toby Medaris

Executive Vice President & Chief Human Resources Officer————

Carolyn Wang

Senior Vice President of Corporate Communications————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 3, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

33

$8.15M

Net Transaction Value

−$8.15M

Net selling

Most Active

SATO VICKI L

9 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 3, 26

de Verneuil Vanina

Direct

Sell$26.7K
Nov 2, 26

de Verneuil Vanina

Direct

Sell$15.2K
Jun 1, 26

Napolitano Janet

Direct

Sell$30.2K
Jun 1, 26

Sabatini Brent

Direct

Sell$3.6K
May 1, 26

SATO VICKI L

Direct

Sell$221K
Apr 6, 26

De Backer Marianne

Direct

Sell$664.4K
Apr 1, 26

SATO VICKI L

Direct

Sell$199.6K
Mar 23, 26

Sabatini Brent

Direct

Sell$70.3K
Mar 2, 26

SATO VICKI L

Direct

Sell$207.2K
Mar 2, 26

SATO VICKI L

Direct

Sell$2K

1–10 of 33

Summary

Insiders reported 0 buys worth $0.00 and 33 sells worth $8.15M over the last 12 months. That adds up to net selling of $8.15M. SATO VICKI L was the most active insider with 9 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-65.1%
+36.8% (5yr)3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
N/A3 analysts

Analysis

Recent growth has been strongest in Revenue at -65.1% over three years. Forward estimates point to Revenue at +36.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Vir Biotechnology, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about VIR's management, answered from reported figures.

Who manages VIR?

Vir Biotechnology, Inc. (VIR) lists 12 active executives. The top listed executive is Jeff Calcagno, Executive Vice President & Chief Business Officer.

Are VIR insiders buying or selling?

Recent insider activity shows net buying of $1.39M.